Home

TAMARA L JOSEPH

CIK 1433991 · Chief Legal Officer · last filed 2024-02-05

TAMARA L JOSEPH is a Chief Legal Officer who has filed 33 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for SPRO, was dated Feb 5, 2024. Across all open-market trades the lifetime net is −$874.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $708.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$708.8K

Companies

4

Total Filings

33

Lifetime Open-Market Net

-$874.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SPRO Chief Legal Officer 562,521 $1.26 $708.8K -$51.0K 6 2024-02-05
Tempest Therapeutics, Inc. (MLND) Delisted General Counsel and Secretary — $15.90 — $0 3 2020-05-27
INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted SVP, General Counsel — $0.32 — $0 3 2017-01-20
CUBIST PHARMACEUTICALS INC (CBST) Delisted SVP, GC & Secretary 19,699 — — -$823.2K 19 2012-07-03

Recent Filings

33 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-02-05 SPRO Mixed +208,825 -$42.3K EDGAR
2023-08-30 SPRO Sell (S) −1,854 -$2.3K EDGAR
2023-02-03 SPRO Mixed +262,563 -$6.3K EDGAR
2022-02-03 SPRO Grant (A) +38,014 $0 EDGAR
2021-08-30 SPRO Grant (A) +24,067 $0 EDGAR
2020-12-02 SPRO Grant (A) — $0 EDGAR
2020-05-27 Tempest Therapeutics, Inc. (MLND) Delisted Grant (A) — $0 EDGAR
2020-02-04 Tempest Therapeutics, Inc. (MLND) Delisted Grant (A) — $0 EDGAR
2019-08-20 Tempest Therapeutics, Inc. (MLND) Delisted Grant (A) — $0 EDGAR
2017-01-20 INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 33
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.